One Global Service Provider Ltd
₹ 168
0.18%
21 Nov
4:00 p.m.
About
Incorporated in 1992, One Global Service Provider Ltd is in the business of healthcare services and related activities.
Key Points
- Market Cap ₹ 119 Cr.
- Current Price ₹ 168
- High / Low ₹ 185 / 36.5
- Stock P/E 12.6
- Book Value ₹ 25.9
- Dividend Yield 0.60 %
- ROCE 84.8 %
- ROE 65.6 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company is expected to give good quarter
- Company has delivered good profit growth of 92.4% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 41.8%
- Company's working capital requirements have reduced from 89.3 days to 57.1 days
Cons
- Promoter holding is low: 29.5%
- Company has high debtors of 152 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
-0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.26 | 1.89 | -0.00 | 3.67 | 6.08 | 18.12 | 63.01 | 71.81 | |
0.10 | 0.25 | 0.10 | 0.08 | 0.09 | 0.07 | 1.62 | 0.18 | 1.18 | 4.70 | 16.46 | 53.29 | 58.99 | |
Operating Profit | -0.10 | -0.25 | -0.10 | -0.08 | -0.09 | 0.19 | 0.27 | -0.18 | 2.49 | 1.38 | 1.66 | 9.72 | 12.82 |
OPM % | 73.08% | 14.29% | 67.85% | 22.70% | 9.16% | 15.43% | 17.85% | ||||||
0.95 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 | |
Interest | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.04 | 0.02 | 0.01 | -0.01 | 0.00 |
Depreciation | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.13 | 0.12 | 0.34 | 0.29 | 0.23 | 0.20 |
Profit before tax | 0.85 | -0.25 | -0.10 | -0.08 | -0.09 | 0.19 | 0.27 | -0.31 | 2.33 | 1.02 | 1.36 | 9.50 | 12.62 |
Tax % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -2.94% | -1.47% | 25.16% | |
0.85 | -0.25 | -0.10 | -0.08 | -0.09 | 0.19 | 0.27 | -0.30 | 2.33 | 1.05 | 1.38 | 7.11 | 9.46 | |
EPS in Rs | 1.20 | -0.35 | -0.14 | -0.11 | -0.13 | 0.27 | 0.38 | -0.42 | 3.28 | 1.48 | 1.94 | 10.01 | 13.32 |
Dividend Payout % | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | 9.99% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 102% |
3 Years: | 158% |
TTM: | 94% |
Compounded Profit Growth | |
---|---|
10 Years: | 41% |
5 Years: | 92% |
3 Years: | 45% |
TTM: | 252% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 95% |
3 Years: | 97% |
1 Year: | 311% |
Return on Equity | |
---|---|
10 Years: | 28% |
5 Years: | 40% |
3 Years: | 42% |
Last Year: | 66% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 | 7.10 |
Reserves | -4.21 | -4.46 | -4.56 | -4.64 | -4.73 | -4.54 | -4.27 | -4.58 | -2.24 | -1.19 | 0.19 | 7.30 | 11.32 |
0.08 | 0.20 | 0.28 | 0.41 | 0.50 | 0.55 | 0.18 | 0.24 | 0.34 | 0.34 | 0.34 | 0.34 | 0.34 | |
0.04 | 0.04 | 0.05 | 0.05 | 0.05 | 1.93 | 0.71 | 0.17 | 1.30 | 2.25 | 5.19 | 17.07 | 20.36 | |
Total Liabilities | 3.01 | 2.88 | 2.87 | 2.92 | 2.92 | 5.04 | 3.72 | 2.93 | 6.50 | 8.50 | 12.82 | 31.81 | 39.12 |
-0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.82 | 1.01 | 0.88 | 0.66 | 0.58 | |
CWIP | 2.77 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | 2.82 | -0.00 |
Investments | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 2.82 |
0.24 | 0.06 | 0.05 | 0.10 | 0.10 | 2.22 | 0.90 | 0.11 | 2.86 | 4.67 | 9.12 | 28.33 | 35.72 | |
Total Assets | 3.01 | 2.88 | 2.87 | 2.92 | 2.92 | 5.04 | 3.72 | 2.93 | 6.50 | 8.50 | 12.82 | 31.81 | 39.12 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1.91 | -0.24 | -0.09 | -0.13 | -0.10 | -0.06 | 0.38 | -0.03 | 0.83 | 0.52 | 0.14 | 1.21 | |
-1.82 | -0.04 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.89 | -0.54 | -0.16 | -0.01 | |
0.08 | 0.11 | 0.09 | 0.13 | 0.09 | 0.05 | -0.37 | 0.06 | 0.10 | -0.00 | -0.00 | -0.00 | |
Net Cash Flow | 0.17 | -0.17 | -0.01 | -0.00 | -0.01 | -0.01 | 0.01 | 0.02 | 0.04 | -0.02 | -0.02 | 1.20 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 365.00 | 148.70 | -0.00 | 241.93 | 163.97 | 151.65 | ||||||
Inventory Days | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | |||||||
Days Payable | ||||||||||||
Cash Conversion Cycle | 365.00 | 148.70 | -0.00 | 241.93 | 163.97 | 151.65 | ||||||
Working Capital Days | 421.15 | 36.69 | 149.18 | 135.07 | 75.74 | 57.12 | ||||||
ROCE % | -3.99% | -8.61% | -3.53% | -2.81% | -3.14% | 6.35% | 8.82% | -10.75% | 59.55% | 18.17% | 19.74% | 84.85% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
16 Nov - Intimation under Regulation 30 and Regulation 47 of SEBI LODR 2015
-
Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year Ended 30Th September, 2024
13 Nov - Non-applicability of Related Party Transaction Report.
-
Outcome Of The Board Meeting Held On Wednesday, 13Th November, 2024
13 Nov - Board approved standalone unaudited financial results.
- RESULT-HALF YEAR ENDED 30-09-2024 ON DATED 13-11-2024 13 Nov
-
Outcome Of The Board Meeting Held On Wednesday, 13Th November, 2024
13 Nov - Board approved standalone unaudited financial results.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
Business Overview:[1]
Company is a Life Sciences and Healthcare Solutions provider with expertise in mass screening, diagnostics, healthcare sciences which are used by hospitals, healthcare professionals and government bodies.